Yipeng Cheng

Feb 15, 2024 | medrxiv.org | Yipeng Cheng |Christian Gieger |Archie Campbell |Andrew McIntosh |Andrew Mcintosh

R.E.M is an advisor to the Epigenetic Clock Development Foundation and Optima Partners. All other authors declare no competing interests. This research was funded in whole, or in part, by the Wellcome Trust [104036/Z/14/Z, 108890/Z/15/Z, 216767/Z/19/Z]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.